ESL Company Overview, Contact Details & Competitors

Q: What is ESL's official website and social media links?

ESL's official website is esluk.com. ESL has social profiles on LinkedIn.

Q: How many employees does ESL have currently?

ESL has approximately 121 employees.

Q: What technology does ESL use?

ESL's tech stack includes Google Fonts API, Akismet, Slider Revolution, RSS, Microsoft.

Q: What is ESL's NAICS code?

ESL's NAICS code is 237 (Heavy and Civil Engineering Construction).

Insights

Gathering insights about ESL…

Similar companies to ESL

ESL Tech Stack

ESL uses 8 technology products and services including Google Call Conversion Tracking, RSS, Open Graph, and more. Explore ESL's tech stack below.

Google Call Conversion Tracking
Analytics
RSS
Content Management System
Open Graph
Content Management System
imagesLoaded
Javascript Libraries
Microsoft Word
Office Suites
Google Tag Manager
Tag Management
Timesheets
Time Tracking
GoDaddy
Web Hosting

Media & News

Estrella Immunopharma to Participate in the D. Boral Capital Global Conference
EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) (“Estrella” or the “Company”), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, today announced that its CEO and CFO will participate in one-on-one investor meetings at the D. Boral Capital 2026 Global Conference. Hosted by D. Boral Capital, this curated forum at The Plaza Hotel brings together executives from emerg.
May 05, 2026 | www.businesswire.com
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) (“Estrella” or the “Company”), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, today announced that Zacks Small-Cap Research (“Zacks SCR”), a division of Zacks Investment Research, has initiated coverage on the Company, assigning a valuation of $12.00 per share. The coverage report highlights the Company's differen.
Mar 23, 2026 | www.businesswire.com
Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR®
EMERYVILLE, Calif.--(BUSINESS WIRE)-- #2026TandemMeetings--Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, presented positive STARLIGHT-1 Phase I results at the 2026 ASTCT & CIBMTR Tandem Meetings (American Society for Transplantation and Cellular Therapy and Center for International Blood & Marrow Transplant Research). The oral prese.
Feb 09, 2026 | www.businesswire.com
Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB103 at the 2026 Tandem Meetings of ASTCT® & CIBMTR®
EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (Nasdaq: ESLA) (“Estrella” or the “Company”), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, today announced its STARLIGHT-1 phase I result will be orally presented at the 2026 ASTCT & CIBMTR Tandem Meetings (American Society for Transplantation and Cellular Therapy and Center for International Blood & Marrow Transplant Researc.
Feb 03, 2026 | www.businesswire.com
Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement
EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (the “Company”), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancers and autoimmune diseases, today announced the closing of its previously announced registered direct offering, with a single healthcare-focused institutional investor, for the issuance and sale of 4,063,290 shares of the Company's common stock and 1,000,000 pre-funded warrants.
Jan 06, 2026 | www.businesswire.com
Estrella Immunopharma, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) (the “Company”), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancers and autoimmune diseases, today announced that it has entered into definitive agreements with a single healthcare-focused institutional investor for the purchase and sale of shares of common stock, par value $0.0001 per share (“Common Stock”) and pre-funded warrants (the “Pre-Funded.
Jan 05, 2026 | www.businesswire.com
Estrella Immunopharma (NASDAQ:ESLA) & Foghorn Therapeutics (NASDAQ:FHTX) Head-To-Head Contrast
Foghorn Therapeutics (NASDAQ: FHTX - Get Free Report) and Estrella Immunopharma (NASDAQ: ESLA - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations. Profitability This table compares Foghorn Therapeutics and
Dec 16, 2025 | www.defenseworld.net

ESL's Email Address Formats

ESL uses at least 2 format(s):

ESL Email Formats	Example	Percentage
First.Last@electrificationsolutions.co.uk	John.Doe@electrificationsolutions.co.uk	100%

Frequently Asked Questions

Where is ESL's headquarters located?

ESL's main headquarters is located at Manchester, England m32 0rs United Kingdom. The company has employees across 4 continents, including EuropeAsiaNorth America.

What is ESL's stock symbol?

ESL is a publicly traded company; the company's stock symbol is ESLA.

What is ESL's official website and social media links?

ESL's official website is esluk.com and has social profiles on LinkedIn.

What is ESL's NAICS code?

ESL's NAICS code is 237 - Heavy and Civil Engineering Construction.

How many employees does ESL have currently?

As of April 2026, ESL has approximately 121 employees across 4 continents, including EuropeAsiaNorth America. Key team members include Business Support Manager: M. G. -. C. M.Lead Cad Technician: J. B.Techiosh - Hsqe Lead: K. G.. Explore ESL's employee directory with LeadIQ.

What industry does ESL belong to?

ESL operates in the Civil Engineering industry.

What technology does ESL use?

ESL's tech stack includes Google Call Conversion TrackingRSSOpen GraphimagesLoadedMicrosoft WordGoogle Tag ManagerTimesheetsGoDaddy.

What is ESL's email format?

ESL's email format typically follows the pattern of First.Last@electrificationsolutions.co.uk. Find more ESL email formats with LeadIQ.

When was ESL founded?

ESL was founded in 2014.

Insights

Similar companies to ESL

Challengermode

Battlefy

UMG Gaming

Toornament

ExitLag Haste

FirstBlood

Start.gg

ESL Tech Stack

Media & News

Estrella Immunopharma to Participate in the D. Boral Capital Global Conference

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research

Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR®

Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB103 at the 2026 Tandem Meetings of ASTCT® & CIBMTR®

Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement

Estrella Immunopharma, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Estrella Immunopharma (NASDAQ:ESLA) & Foghorn Therapeutics (NASDAQ:FHTX) Head-To-Head Contrast

ESL's Email Address Formats

Frequently Asked Questions

Where is ESL's headquarters located?

What is ESL's stock symbol?

What is ESL's official website and social media links?

What is ESL's NAICS code?

How many employees does ESL have currently?

What industry does ESL belong to?

What technology does ESL use?

What is ESL's email format?

When was ESL founded?

ESL

Company Overview

Media & News

Estrella Immunopharma to Participate in the D. Boral Capital Global Conference

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research

Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR®

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?